About 620 products see price reduction after trade margin regulation on critical medical devicesOn July 13, the National Pharmaceuticals Pricing Authority (NPPA) had invoked extraordinary powers under the Paragraph 19 of DPCO, 2013, to...
Government caps trade margin on pulse oximeter, nebuliser, digital thermometer at 70 percentThe National Pharmaceuticals Pricing Authority (NPPA) has invoked extraordinary powers under the Paragraph 19 of DPCO, 2013, to put a cap o...
Govt caps trade margin on oxygen concentrators at 70 pcIn an official release, the Chemicals and Fertilisers Ministry said the decision has been taken in view of the extraordinary circumstances ...
Encouraging innovation: Government may move 'innovative' knee implants out of price controlThe National Pharmaceutical Pricing Authority (NPPA) “is deliberating on the ceiling prices of the knee implants as there have been demands...
Centre caps MRP of 3 ply meltblown face masks at Rs 16/piece till June 30On March 21, the Consumer Affairs Ministry had notified MRP for 2 ply and 3 ply 'surgical' face masks at Rs 8 and Rs 10 per piece, respecti...
TRAI lowers cap on MRP of individual channelsTRAI has reduced the cap on the MRP of individual channels to Rs 12 per month, from Rs 19.
Trai moves Supreme Court for discount cap on channel bouquetsIndia’s telecom regulator has moved the Supreme Court seeking an order to reinstate the 15% cap on discounting of channel bouquets.
Government extends caps price of knee implants for one more yearProviding relief to patients going for knee implants, the National Pharmaceutical Pricing Authority (NPPA) has extended the ceiling prices ...
Buy Equitas Holdings, target Rs 160: Manas JaiswalBuy Equitas Holdings Ltd. at a price target of Rs 160.0 and a stop loss at Rs 149 from the entry point.
Consumables now costlier than stents in angioplastyMany hospitals are charging anything between Rs 32,000-42,000 and some even more, well above the cost of a stent, which has been capped at ...
- Buy Equitas Holdings, target Rs 175: Kunal Bothra
Buy Equitas Holdings Ltd. at a price target of Rs 175.0 and a stop loss at Rs 157 from entry point.
- Buy Equitas Holdings, target Rs 160: Shrikant Chouhan
Buy Equitas Holdings Ltd. at a price target of Rs 160.0 and a stop loss at Rs 144 from entry point.
- Buy Equitas Holdings, target Rs 155: Manas Jaiswal
Buy Equitas Holdings Ltd. at a price target of Rs 155.0 and a stop loss at Rs 143 from entry point.
Rein in MRP or government will, syringe makers toldThe NPPA had issued notice to the hospital following allegations of over-charging by the parents of the girl who died after leaving the hos...
MRP of stents, valves must now be declaredThe new rules also makes it mandatory for ecommerce firms to mention MRP of products, which is aimed at ending any ambiguity.
Put price cap on medicines, hip & knee implants: Doctors to PMIn a letter to PM Modi, the Alliance of Doctors for Ethical Healthcare (ADEH) said these drugs and implants are also charged "exorbitantly"...
Cap profits, cut drug prices: PanelThe recommendations have been put in the public domain by the Department of Pharmaceuticals, inviting comments on the suggestions.